Stunting is characterized by chronic inflammation in zimbabwean infants

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Prendergast, Andrew J ^a,b,c   Rukobo, Sandra ^b   Chasekwa, Bernard ^b   Mutasa, Kuda ^b   Ntozini, Robert ^b   Mbuya, Mduduzi N N ^b,c   Jones, Andrew ^d   Moulton, Lawrence H ^c   Stoltzfus, Rebecca J ^e   Humphrey, Jean H ^b,c  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b Zvitambo Institute for Maternal and Child Health Research   (Zimbabwe)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CD14 ANTIGEN; FATTY ACID BINDING PROTEIN; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 6; OROSOMUCOID; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; BIOLOGICAL MARKER; HUMAN GROWTH HORMONE; IGF1 PROTEIN, HUMAN; IGFBP3 PROTEIN, HUMAN;

ARTICLE; BIRTH WEIGHT; CASE CONTROL STUDY; CHRONIC INFLAMMATION; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ETHNIC GROUP; FEMALE; HUMAN; INFANT; INTESTINE FLORA; INTESTINE INJURY; MAJOR CLINICAL STUDY; MALE; MATERNAL PLASMA; MOTHER; PROTEIN BLOOD LEVEL; STUNTING; ZIMBABWE; ZIMBABWEAN; ANTHROPOMETRY; BLOOD; EPIDEMIOLOGY; GROWTH DISORDERS; HIV INFECTIONS; INFLAMMATION; METABOLISM; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PRESCHOOL CHILD; RISK; STATISTICAL MODEL;

ANTHROPOMETRY; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHILD, PRESCHOOL; FEMALE; GROWTH DISORDERS; HIV INFECTIONS; HUMAN GROWTH HORMONE; HUMANS; INFLAMMATION; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; INTERLEUKIN-6; MALE; MODELS, STATISTICAL; MULTIVARIATE ANALYSIS; ODDS RATIO; ZIMBABWE;

EID: 84897814243     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0086928     Document Type: Article

References (40)

1. Black RE, Victora CG, Walker SP, Bhutta ZA, Christian P, et al. (2013) Maternal and child undernutrition and overweight in low-income and middle-income countries. Lancet 382: 427-451.
2. Victora CG, Adair L, Fall C, Hallal PC, Martorell R, et al. (2008) Maternal and child undernutrition: consequences for adult health and human capital. Lancet 371: 340-357.
3. Victora CG, de Onis M, Hallal PC, Blossner M, Shrimpton R (2010) Worldwide timing of growth faltering: revisiting implications for interventions. Pediatrics 125: e473-480.
4. Dewey KG, Adu-Afarwuah S (2008) Systematic review of the efficacy and effectiveness of complementary feeding interventions in developing countries. Maternal and Child Nutrition: Blackwell Publishing Ltd: Program in International and Community Nutrition, University of California, Davis, CA, USA.
5. Briend A (1990) Is diarrhoea a major cause of malnutrition among the under-fives in developing countries? A review of available evidence. Eur J Clin Nutr 44: 611-628.
6. Briend A, Hasan KZ, Aziz KM, Hoque BA (1989) Are diarrhoea control programmes likely to reduce childhood malnutrition? Observations from rural Bangladesh. Lancet 2: 319-322. (Pubitemid 19187039)
7. Moy RJ, de CMTF, Choto RG, McNeish AS, Booth IW (1994) Diarrhoea and growth faltering in rural Zimbabwe. European Journal of Clinical Nutrition 48: 810-821.
8. Poskitt EM, Cole TJ, Whitehead RG (1999) Less diarrhoea but no change in growth: 15 years' data from three Gambian villages. Archives of Disease in Childhood 80: 115-119; discussion 119-120.
9. Solomons NW, Mazeriegos M, Brown KH, Klasing K (1993) The underprivileged, developing country child: environmental contamination and growth failure revisited. Nutrition Reviews 51: 327-332. (Pubitemid 24022565)
10. Humphrey JH (2009) Child undernutrition, tropical enteropathy, toilets, and handwashing. Lancet 374: 1032-1035.
11. Desai HG, Borkar AV, Pathare SM, Dighe PK, Jeejeebhoy KN (1969) 'Flat' jejunal mucosa in the tropics. Indian Journal of Medical Sciences 23: 1-5.
12. Schenk EA, Samloff IM, Klipstein FA (1968) Morphology of small bowel biopsies. The American Journal of Clinical Nutrition 21: 944-961.
13. Menzies IS, Zuckerman MJ, Nukajam WS, Somasundaram SG, Murphy B, et al. (1999) Geography of intestinal permeability and absorption. Gut 44: 483-489. (Pubitemid 29169947)
14. Prendergast A, Kelly P (2012) Review: Enteropathies in the developing world: neglected effects on global health. Am J Trop Med Hyg 86: 756-763.
15. Lunn PG, Northrop-Clewes CA, Downes RM (1991) Intestinal permeability, mucosal injury, and growth faltering in Gambian infants. Lancet 338: 907-910.
16. De Benedetti F, Alonzi T, Moretta A, Lazzaro D, Costa P, et al. (1997) Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-1. J Clin Invest 99: 643-650.
17. Walters TD, Griffiths AM (2009) Mechanisms of growth impairment in pediatric Crohn's disease. Nat Rev Gastroenterol Hepatol 6: 513-523.
18. Humphrey JH, Iliff PJ, Marinda ET, Mutasa K, Moulton LH, et al. (2006) Effects of a single large dose of vitamin A, given during the postpartum period to HIV-positive women and their infants, on child HIV infection, HIV-free survival, and mortality. The Journal of Infectious Diseases 193: 860-871.
19. Iliff PJ, Piwoz EG, Tavengwa NV, Zunguza CD, Marinda ET, et al. (2005) Early exclusive breastfeeding reduces the risk of postnatal HIV-1 transmission and increases HIV-free survival. AIDS 19: 699-708. (Pubitemid 40593075)
20. Gibson RS (1990) Principles of nutritional assessment: New York Oxford.
21. Newson R (2002) Parameters behind "nonparametric" statistics: Kendall's tau, Somers' D and median differences. The Stata Journal 2: 45-64.
22. Lieberman JM, Sacchettini J, Marks C, Marks WH (1997) Human intestinal fatty acid binding protein: Report of an assay with studies in normal colunteers and intestinal ischemia. Surgery 121: 335-342. (Pubitemid 27114453)
23. Gauldie J, Richards C, Harnish D, Lansdorp P, Baumann H (1987) Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proceedings of the National Academy of Sciences of the United States of America 84: 7251-7255.
24. Gabay C, Kushner I (1999) Acute-phase proteins and other systemic responses to inflammation. The New England Journal of Medicine 340: 448-454. (Pubitemid 29084777)
25. Jensen RB, Jeppesen KA, VielwertMichaelsen KF, Main KM, Skakkebaek NE, et al. (2005) Insulin-like growth factor I (IGF-I) and IGF-binding protein 3 as diagnostic markers of growth hormone deficiency in infancy. Horm Res 63: 15-21.
26. Yuksel B, Ozbek MN, Mungan NO, Darendeliler F, Budan B, et al. (2011) Serum IGF-1 and IGFBP-3 levels in healthy children between 0 and 6 years of age. J Clin Res Ped Endo 3: 84-88.
27. Baalwa J, Byarugaba BB, Kabagambe KE, Otim AM (2010) Prevalence of overweight and obesity in young adults in Uganda. African Health Sciences 10: 367-373.
28. Shayo GA, Mugusi FM (2011) Prevalence of obesity and associated risk factors among adults in Kinondoni municipal district, Dar es Salaam Tanzania. BMC Public Health 11: 365.
29. Campbell DI, Elia M, Lunn PG (2003) Growth faltering in rural Gambian infants is associated with impaired small intestinal barrier function, leading to endotoxemia and systemic inflammation. J Nutr 133: 1332-1338. (Pubitemid 36548703)
30. Derikx JPM, Vreugdenhil ACE, Van den Neucker AM, Grootjans J, van Bijnen AA, et al. (2009) A pilot study on the noninvasive evaluation of intestinal damage in celiac disease using I-FABP and L-FABP. J Clin Gastroenterol 43: 727-733.
31. Derikx JP, Bijker EM, Vos GD, van Bijnen AA, Heineman E, et al. (2010) Gut mucosal cell damage in meningococcal sepsis in children: relation with clinical outcome. Critical Care Medicine 38: 133-137.
32. Sandler NG, Wand H, Roque A, Law M, Nason MC, et al. (2011) Plasma levels of soluble CD14 independently predict mortality in HIV infection. The Journal of Infectious Diseases 203: 780-790.
33. Vreugdenhil AC, Wolters VM, Adriaanse MP, Van den Neucker AM, van Bijnen AA, et al. (2011) Additional value of serum I-FABP levels for evaluating celiac disease activity in children. Scandinavian Journal of Gastroenterology 46: 1435-1441.
34. Kosek M, Haque R, Lima A, Babji S, Shrestha S, et al. (2013) Fecal markers of intestinal inflammation and permeability associated with the subsequent acquisition of linear growth deficits in infants. The American Journal of Tropical Medicine and Hygiene 88: 390-396.
35. Peterson KM, Buss J, Easley R, Yang Z, Korpe PS, et al. (2013) REG1B as a predictor of childhood stunting in Bangladesh and Peru. The American Journal of Clinical Nutrition 97: 1129-1133.
36. Lin A, Arnold BF, Afreen S, Goto R, Huda TM, et al. (2013) Household environmental conditions are associated with enteropathy and impaired growth in rural Bangladesh. The American Journal of Tropical Medicine and Hygiene 89: 130-137.
37. Liu JR, Sheng XY, Hu YQ, Yu XG, Westcott JE, et al. (2012) Fecal calprotectin levels are higher in rural than in urban Chinese infants and negatively associated with growth. BMC Pediatrics 12: 129.
38. Kitchens RL, Thompson PA (2005) Modulatory effects of sCD14 and LBP on LPS-host cell interactions. J Endotoxin Res 11: 225-229. (Pubitemid 41358857)
39. Semple S, Devakumar D, Fullerton DG, Thorne PS, Metwali N, et al. (2010) Airborne endotoxin concentrations in homes burning biomass fuel. Environmental Health Perspectives 118: 988-991.
40. Keusch GT, Rosenberg IH, Denno DM, Duggan C, Guerrant RL, et al. (2013) Implications of acquired environmental enteric dysfunction for growth and stunting in infants and children living in low- and middle-income countries. Food and Nutrition Bulletin 34: 357-364.